Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating Activities
Net income (loss)	$ 4,078	$ (3,311)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	58,984	62,266
Loss on disposal of assets	408	412
Share-based compensation expense	32,526	30,277
Deferred income taxes	1,233	(9,401)
Amortization of operating lease right-of-use assets	5,868	5,279
Inventory write-down	0	5,393
Amortization of debt issuance costs	2,155	2,917
Changes in operating assets and liabilities:
Accounts receivable and unbilled receivables	12,450	1,174
Inventories	(17,731)	10,038
Prepaid expenses	(4,305)	(2,918)
Other current assets	(10,037)	8,354
Investment in sales-type leases	(2,493)	(7,453)
Prepaid commissions	2,097	2,684
Other long-term assets	5,919	1,048
Accounts payable	10,695	2,945
Accrued compensation	(10,999)	(6,664)
Accrued liabilities	(13,059)	6,963
Deferred revenues	26,901	27,746
Operating lease liabilities	(8,753)	(8,021)
Other long-term liabilities	1,009	1,679
Net cash provided by operating activities	96,946	131,407
Investing Activities
External-use software development costs	(13,237)	(11,849)
Purchases of property and equipment	(32,706)	(27,376)
Net cash used in investing activities	(45,943)	(39,225)
Financing Activities
Repayment of convertible senior notes due 2025	(175,000)	0
Proceeds from issuances under stock-based compensation plans	15,162	13,140
Employees’ taxes paid related to restricted stock units	(5,963)	(3,544)
Common stock repurchases	(77,600)	0
Change in customer funds, net	15,989	(10,744)
Net cash used in financing activities	(227,412)	(1,148)
Effect of exchange rate changes on cash and cash equivalents	3,250	879
Net increase (decrease) in cash, cash equivalents, and restricted cash	(173,159)	91,913
Cash, cash equivalents, and restricted cash at beginning of period	398,614	500,979
Cash, cash equivalents, and restricted cash at end of period	225,455	592,892
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	180,053	570,628
Restricted cash included in other current assets	45,402	22,264
Cash, cash equivalents, and restricted cash at end of period	225,455	592,892
Supplemental disclosure of non-cash investing and financing activities:
Unpaid purchases of property and equipment	510	432
Excise tax payable on common stock repurchases	$ 442	$ 0